FDA To Fill Frankos' Shoes As Major Dietary Supplement Initiatives Pend
This article was originally published in The Tan Sheet
Executive Summary
The successor to Vasilios "Bill" Frankos, FDA's director of Dietary Supplement Programs, will face a full plate of imminent and ongoing regulatory issues
You may also be interested in...
Supplement Firms Have ‘Continuous Monitoring’ Burden To Show Product Safety
Former FDA supplement programs head Bill Frankos says the industry bears the burden for monitoring product safety in the marketplace because FDA does not have the same vested interest it has for drugs and medical devices stemming from pre-market approval of the products.
Supplement Firms Have ‘Continuous Monitoring’ Burden To Show Product Safety
Former FDA supplement programs head Bill Frankos says the industry bears the burden for monitoring product safety in the marketplace because FDA does not have the same vested interest it has for drugs and medical devices stemming from pre-market approval of the products.
Supplement Firms Have ‘Continuous Monitoring’ Burden To Show Product Safety
Former FDA supplement programs head Bill Frankos says the industry bears the burden for monitoring product safety in the marketplace because FDA does not have the same vested interest it has for drugs and medical devices stemming from pre-market approval of the products.